Dr. Roger S. Keresztes, MD
- Medicare services, 2024
- 902
- Medicare patients, 2024
- 258
- Part D claims, 2024
- 543
- Publications
- 10
- Clinical trials
- 10
- Practice address
- 3 Edmund D Pellegrino Rd, Stony Brook, NY 11794
- Practice phone
- Call (631) 444-2448
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Stony Brook Internists
Primary care practice · Stony Brook, New York
Find Dr. Keresztes' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Roger S. Keresztes is a hematologist and oncologist in Stony Brook, New York
Dr. Keresztes practices at Stony Brook Internists in Stony Brook, New York.
Dr. Keresztes' NPI, 1770638868, was assigned on January 25, 2007. Dr. Keresztes graduated from Rutgers New Jersey Medical School in 1987. Dr. Keresztes holds New York license 180051.
- NPI
- 1770638868NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4183728751
- NPI enumeration date
- January 25, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (631) 444-2448
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 65
- Medical school graduation
- 1987
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Roger S. Keresztes practices at Stony Brook Internists in Stony Brook, New York
Dr. Keresztes' primary practice is Stony Brook Internists, at 3 Edmund D Pellegrino Rd, Stony Brook, NY 11794. The practice phone is (631) 444-2448.
- Stony Brook Internists3 Edmund D Pellegrino Rd, Stony Brook, NY 11794Phone(631) 444-2448
Source: Dmand AI Affiliation Data
Dr. Roger S. Keresztes is affiliated with 4 sites of care and 1 medical group
Dr. Keresztes' primary practice is Stony Brook Internists in Stony Brook, New York. Dr. Keresztes is also affiliated with Stony Brook University Hospital. The medical group on file is Stony Brook Internists. Dmand AI also links Dr. Keresztes to 1 more home health agency and 1 hospice, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Roger S. Keresztes' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keresztes practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Stony Brook Internists | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Roger S. Keresztes is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Keresztes' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Keresztes is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Keresztes
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Roger S. Keresztes billed Medicare for 902 services in 2024
CMS data shows 902 Medicare services from Dr. Keresztes across 7 procedure codes in 2024, for 258 Medicare patients. Medicare paid $85,643 for them.
Dr. Keresztes' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 9992024: 90210%
Where Dr. Keresztes' Medicare services took place, 2024
- In an office69777%
- In a facility20523%
Dr. Keresztes compared with the New York median for hematologists and oncologists, 2024
- Dr. Keresztes
- New York median
- Medicare services
- 902vs 66835% above
- Medicare patients
- 258vs 21023% above
- Part D claims
- 324vs 25826% above
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Keresztes' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Keresztes?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Keresztes and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Roger S. Keresztes treated 258 Medicare patients in 2024, average age 75
CMS counts 258 Medicare patients who saw Dr. Keresztes in 2024. The largest group is 75 to 84, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Keresztes' median patient age at 72, with 37% women.
Dr. Keresztes' Medicare patients by age, 2024
Dr. Keresztes' Medicare patients by sex, 2024
- Women11545%
- Men14355%
Chronic conditions among Dr. Keresztes' Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer71%
- Ischemic heart disease47%
- Arthritis41%
- COPD40%
- Diabetes37%
- Chronic kidney disease33%
Share of Medicare patients with each condition. A patient can have several.
Dr. Keresztes' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women37%
- Men61%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Roger S. Keresztes wrote 543 Medicare Part D claims in 2024
In 2024, Dr. Keresztes wrote 543 Medicare Part D claims for 97 patients. 78% of them were for generic drugs. CMS names the drug for 324 of them, across 14 drugs with 11 or more claims each, at $982,407 in total drug cost. In 2023, CMS named 226 claims across 10 drugs.
Dr. Keresztes' Part D claims by kind of drug, 2024
- Generic421 claims78%
- Brand-name and other122 claims22%
Dr. Keresztes' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Keresztes' Part D claims, 2024
- Opioids18%98 of 543 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2262024: 32443%
Drugs named by CMS: 14 in 2024, 10 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Roger S. Keresztes takes part in Medicare
Dr. Keresztes accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Roger S. Keresztes has 10 publications on record
Dmand AI links 10 papers to Dr. Keresztes, published from 2011 to 2021. 2017 was the busiest year, with 2. The most frequent topics are Carcinoma, Non-Small-Cell Lung and Lung Neoplasms. Dr. Keresztes' most frequent co-authors are Thomas Bilfinger, MD, Bruce E. Culliney, MD and Tracey L. Evans, MD.
Dr. Keresztes' papers by year, 2011 to 2021
Topics Dr. Keresztes writes about most
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Dr. Keresztes' most frequent co-authors
- Thomas Bilfinger, MD2 shared papers
- Bruce E. Culliney, MD1 shared paper
- Tracey L. Evans, MD1 shared paper
Recent publications by Dr. Keresztes
See who Dr. Keresztes researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Keresztes works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Roger S. Keresztes has worked on 10 clinical trials
Dmand AI links Dr. Keresztes to 10 clinical trials, 5 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Cystadenocarcinoma, Mucinous. National Cancer Institute (NCI) sponsors the most, 3.
Clinical trials with Dr. Keresztes by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Keresztes' trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Cystadenocarcinoma, Mucinous
- Inhibition, Psychological
- Carcinoma, Giant Cell
Investigators on the most trials with Dr. Keresztes
- Fariborze B. Barhamand, MD5 shared trials
- Shobha Rani Chitneni, MD5 shared trials
- Elward David Crawford, MD5 shared trials
Recent clinical trials with Dr. Keresztes
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (opens in a new tab)
QUILT 2.023: A Study of N-803 in Combination With Current Standard of Care vs Standard of Care as First-Line Treatment for Patients With Stage 3 or 4 NSCLC. (opens in a new tab)
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer (opens in a new tab)
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (opens in a new tab)
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Roger S. Keresztes received $129 in industry payments from 2016 to 2025
CMS Open Payments shows 6 general payments to Dr. Keresztes from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $44.
General payments to Dr. Keresztes by program year, 2016 to 2025
Companies that paid Dr. Keresztes the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Roger S. Keresztes graduated from Rutgers New Jersey Medical School
Dr. Keresztes graduated from Rutgers New Jersey Medical School in 1987.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Roger S. Keresztes's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Roger S. Keresztes
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Roger S. Keresztes' NPI number?
Dr. Roger S. Keresztes' NPI number is 1770638868. It was assigned on January 25, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Roger S. Keresztes?
Dr. Roger S. Keresztes is a hematologist and oncologist in Stony Brook, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Roger S. Keresztes practice?
Dr. Keresztes practices at 3 Edmund D Pellegrino Rd, Stony Brook, NY 11794. Dr. Keresztes' primary practice is Stony Brook Internists in Stony Brook, New York. Dmand AI also links Dr. Keresztes to 1 home health agency and 1 hospice.
What is Dr. Roger S. Keresztes' office phone number?
The practice phone on file for Dr. Keresztes is (631) 444-2448.
What is Dr. Roger S. Keresztes' medical license number?
Dr. Keresztes holds New York license 180051.
Which hospitals is Dr. Roger S. Keresztes affiliated with?
Dr. Keresztes is affiliated with Stony Brook University Hospital.
What medical group is Dr. Roger S. Keresztes part of?
Dr. Keresztes is linked to Stony Brook Internists.
Does Dr. Roger S. Keresztes accept Medicare?
Yes. CMS data shows Dr. Keresztes billed Medicare for 902 services in 2024, and Dr. Keresztes accepts Medicare assignment.
How many Medicare patients does Dr. Roger S. Keresztes see?
CMS counts 258 Medicare patients who saw Dr. Keresztes in 2024, with an average age of 75.
What services does Dr. Roger S. Keresztes bill to Medicare?
In 2024, Dr. Keresztes' most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and hospital inpatient care (99232).
Show 6 more questionsShow fewer questions
Where did Dr. Roger S. Keresztes go to medical school?
Dr. Keresztes graduated from Rutgers New Jersey Medical School in 1987.
What drugs does Dr. Roger S. Keresztes prescribe most?
In 2024 Medicare Part D data, Dr. Keresztes' most prescribed drugs by claims were Levothyroxine Sodium, Ondansetron HCl and Oxycodone HCl.
Has Dr. Roger S. Keresztes received payments from drug or device companies?
CMS Open Payments shows $129 in general payments to Dr. Keresztes from 4 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Roger S. Keresztes been practicing?
Dr. Keresztes graduated from medical school in 1987, 39 years ago.
Does Dr. Roger S. Keresztes do research?
Dmand AI links 10 publications to Dr. Keresztes, published from 2011 to 2021. Dr. Keresztes has worked on 10 clinical trials.
Who does Dr. Roger S. Keresztes publish with?
Dr. Keresztes' most frequent co-authors are Thomas Bilfinger, MD (2 shared papers), Bruce E. Culliney, MD (1 shared paper) and Tracey L. Evans, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card